Related Experiment Video
Updated: Apr 25, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Hepatitis B core antibody-positive donors in cardiac transplantation: a single-center experience
J L Horan1, J E Stout, B D Alexander
1Department of Medicine/Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA.
Insights
Hepatitis B core antibody (HBcAb)-positive donors are safe for heart transplants. A study found no HBV transmission in recipients from 18 HBcAb-positive donors, even with low viral DNA levels.
Area of Science:
- Transplantation immunology
- Virology
- Infectious diseases
Background:
- Hepatitis B core antibody (HBcAb)-positive donors are increasingly used in organ transplantation.
- Assessing the risk of Hepatitis B virus (HBV) transmission from these donors is crucial.
Purpose of the Study:
- To evaluate the safety and outcomes of using HBcAb-positive donors in cardiac transplantation.
- To determine the incidence of donor-derived HBV transmission in heart transplant recipients.
Main Methods:
- Retrospective analysis of a single center's experience.
- Inclusion of 18 cardiac allografts from HBcAb-positive donors.
- Review of recipient follow-up data, including cases with detectable HBV DNA in donor serum.
Main Results:
- No documented cases of donor-derived HBV transmission were observed in recipients.
- This finding held true even for two donors with low-level serum HBV DNA at the time of transplantation.
- Allograft function and patient survival data were not detailed but the primary outcome of transmission was negative.
Conclusions:
- Cardiac transplantation using HBcAb-positive donors, even those with low HBV DNA, appears safe regarding HBV transmission.
- This study supports the continued utilization of HBcAb-positive donors in heart transplantation programs.
- Further research may explore long-term outcomes and risk stratification in this donor population.
Abstract:
Hepatitis B virus (HBV) core antibody (HBcAb)-positive donors are increasingly utilized in solid organ transplantation. We report a single center's experience in cardiac transplantation with 18 HBcAb-positive donors. Available follow-up on recipients of cardiac allografts from HBcAb-positive donors, including 2 donors with low-level serum HBV DNA at the time of transplantation, demonstrated no documented donor-derived HBV transmission.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hepatitis
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

